LMR Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-863,134
| Closed | -$114M | – | 1739 |
|
|
2025
Q1 | $114M | Buy |
863,134
+854,957
| +10,456% | +$107M | 1.07% | 9 |
|
|
2024
Q4 | $683K | Sell |
8,177
-23,000
| -74% | -$1.89M | 0.01% | 783 |
|
|
2024
Q3 | $2.28M | Sell |
31,177
-2,112
| -6% | -$159K | 0.02% | 569 |
|
|
2024
Q2 | $2.28M | Buy |
33,289
+12,329
| +59% | +$855K | 0.02% | 519 |
|
|
2024
Q1 | $1.45M | Buy |
+20,960
| New | +$1.44M | 0.01% | 614 |
|
|
2023
Q4 | – | Sell |
-4,700
| Closed | -$270K | – | 1162 |
|
|
2023
Q3 | $245K | Buy |
+4,700
| New | +$274K | ﹤0.01% | 620 |
|
|
2022
Q4 | – | Sell |
-7,900
| Closed | -$368K | – | 1309 |
|
|
2022
Q3 | $368K | Hold |
7,900
| – | – | 0.01% | 933 |
|
|
2022
Q2 | $451K | Sell |
7,900
-7,500
| -49% | -$425K | 0.01% | 949 |
|
|
2022
Q1 | $942K | Buy |
+15,400
| New | +$800K | 0.01% | 848 |
|
|
2021
Q4 | – | Sell |
-12,000
| Closed | -$447K | – | 1306 |
|
|
2021
Q3 | $447K | Buy |
+12,000
| New | +$417K | 0.01% | 821 |
|
|
2020
Q2 | – | Sell |
-50,000
| Closed | -$791K | – | 651 |
|
|
2020
Q1 | $791K | Sell |
50,000
-50,000
| -50% | -$1.09M | 0.04% | 143 |
|
|
2019
Q4 | $3.43K | Buy |
+100,000
| New | +$1.2M | 0.01% | 97 |
|
Other funds holding ITCI
KIM
HNB